​

Funding Round

Series B - Vividion Therapeutics

Series B - Vividion Therapeutics

Investment Firm

Overview

Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.

Announced Date

Apr 30, 2019

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Nextech Invest

Nextech Invest

Nextech Invest is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

12

Investor Name
Participant InvestorCardinal Partners
Participant InvestorNextech Invest
Participant InvestorCelgene
Participant InvestorVersant Ventures
Participant InvestorARCH Venture Partners

Round Details and Background

Vividion Therapeutics raised $82000000 on 2019-04-30 in Series B

Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 30, 2019
Series B - Vividion Therapeutics
12-82.0M
Feb 24, 2021
Series C - Vividion Therapeutics
16-135.0M
Feb 02, 2017
Series A - Vividion Therapeutics
3-50.0M
Apr 11, 2016
Series A - Vividion Therapeutics
1-3.5M

Recent Activity

There is no recent news or activity for this profile.